SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
LFB Biotechnologies's Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in Europe for Chronic Lymphocytic Leukemia